THE BEST SIDE OF MBL77

Not all patients with CLL require therapy. Irrespective of all latest innovations, the iwCLL still suggests watchful observation for individuals with asymptomatic disease.86 This advice relies on at least two randomized trials evaluating observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 Both